Literature DB >> 18607141

Secondary hypertension: interfering substances.

Ehud Grossman1, Franz H Messerli.   

Abstract

A variety of therapeutic agents or chemical substances can induce either a transient or persistent increase in blood pressure or interfere with the blood pressure-lowering effects of antihypertensive drugs. Some agents either cause sodium retention and extracellular volume expansion or directly or indirectly activate the sympathetic nervous system. Other substances act directly on arteriolar smooth muscle or do not have a defined mechanism of action. Some medications that usually lower blood pressure may paradoxically increase blood pressure, and an increase in pressure may be encountered after their discontinuation. In general, these pressure increases are small and transient; however, severe hypertension involving encephalopathy, stroke, and irreversible renal failure have been reported. Careful evaluation of a patient's drug regimen may identify chemically induced hypertension and obviate unnecessary evaluation and direct to the optimal antihypertensive therapy. The present review summarizes the therapeutic agents or chemical substances that elevate blood pressure and their mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607141      PMCID: PMC8109893          DOI: 10.1111/j.1751-7176.2008.07758.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  76 in total

Review 1.  Herbal interactions with cardiovascular drugs.

Authors:  Dennis V C Awang; Adriane Fugh-Berman
Journal:  J Cardiovasc Nurs       Date:  2002-07       Impact factor: 2.083

2.  Exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Public Health and Environmental Exposure to Cadmium Study Group.

Authors:  J A Staessen; T Kuznetsova; H A Roels; D Emelianov; R Fagard
Journal:  Am J Hypertens       Date:  2000-02       Impact factor: 2.689

3.  Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure.

Authors:  Tai-Juan Aw; Steven Joseph Haas; Danny Liew; Henry Krum
Journal:  Arch Intern Med       Date:  2005-02-14

Review 4.  Erythropoietin and arterial hypertension.

Authors:  F C Luft
Journal:  Clin Nephrol       Date:  2000-02       Impact factor: 0.975

5.  Relationship of alcohol consumption to 7-year blood pressure change in Japanese men.

Authors:  Katsushi Yoshita; Katsuyuki Miura; Yuko Morikawa; Masao Ishizaki; Teruhiko Kido; Yuchi Naruse; Yoshiyuki Soyama; Yasushi Suwazono; Koji Nogawa; Hideaki Nakagawa
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

6.  Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

Authors:  Joshua A Samuels; Kathy Franco; Fiona Wan; Jonathan M Sorof
Journal:  Pediatr Nephrol       Date:  2005-10-28       Impact factor: 3.714

Review 7.  Cyclosporine in idiopathic nephrotic syndrome.

Authors:  C Ponticelli
Journal:  Immunopharmacol Immunotoxicol       Date:  1993-08       Impact factor: 2.730

8.  Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics.

Authors:  Munavvar Izhar; Tunji Alausa; Amy Folker; Elena Hung; George L Bakris
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

Review 9.  The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents.

Authors:  Edward P Armstrong; Daniel C Malone
Journal:  Clin Ther       Date:  2003-01       Impact factor: 3.393

10.  Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis.

Authors:  T P Loughran; H J Deeg; S Dahlberg; M S Kennedy; R Storb; E D Thomas
Journal:  Br J Haematol       Date:  1985-03       Impact factor: 6.998

View more
  3 in total

Review 1.  Resistant hypertension: concepts and approach to management.

Authors:  Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

2.  Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.

Authors:  Andrew Y Hwang; Chintan V Dave; Steven M Smith
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

Review 3.  Severe hypertension in children and adolescents: pathophysiology and treatment.

Authors:  Joseph T Flynn; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.